UroMems is taking a new step in its development. Eybens' medtech, which is developing an intelligent implant against urinary incontinence, announces a record $60 million fundraiser to accelerate its clinical trials before commercialization in Europe and the United States.
UroMems is taking a new step in its development. Eybens' medtech, which is developing an intelligent implant against urinary incontinence, announces a record $60 million fundraiser to accelerate its clinical trials before commercialization in Europe and the United States.